Aadi Bioscience Inc. (AADI)
NASDAQ: AADI
· Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM
-2.38% (1D)
| Bid | 2.03 |
| Market Cap | 94.89M |
| Revenue (ttm) | 25.98M |
| Net Income (ttm) | -63.69M |
| EPS (ttm) | -2.36 |
| PE Ratio (ttm) | -0.8686440677966102 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 2.06 |
| Volume | 62,607 |
| Avg. Volume (20D) | 200,709 |
| Open | 2.15 |
| Previous Close | 2.10 |
| Day's Range | 2.02 - 2.19 |
| 52-Week Range | 1.21 - 3.81 |
| Beta | 0.34 |
About AADI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AADI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AADI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Aadi Bioscience Inc. is scheduled to release its earnings on May 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+46.12%
Aadi Bioscience shares are trading higher after th...
Unlock content with
Pro Subscription
9 months ago
-4.32%
Aadi Bioscience shares are trading lower after the company announced an analysis by the Independent Data Monitoring Committee demonstrated that the study was unlikely to exceed an efficacy threshold necessary to support an accelerated approval. The company will pause new enrollment and is reducing its Research & Development workforce by 80%.
